It was the year 2005 when India adopted patent regeime. The worst fear which was projected was that of loosing India's strength over pharmaceutical development and manufacturing.
Much of that fear has already lost withn last 3 years. On the contarary, the MNCs operating in India from at least last 40 to 50 years have eroded their market captelisation.
The Pfizer, Novartis and Merck have all lost the glory of their past days operation in India. With nothing much to offer from their global new product basket, these companies continue to struggle over pricing issues.
To read the complete storey published in Economic Times, click here.